We are live on
!
Find out more
RWJF
Robert Wood Johnson Foundation Portfolio holdings
AUM
$125M
1-Year Est. Return
15.63%
This Fund
S&P 500
This Quarter
Est. Return
+6.75%
1 Year Est. Return
+15.63%
3 Year Est. Return
+22.87%
5 Year Est. Return
+15.87%
10 Year Est. Return
+24.67%
AUM
$2.07B
AUM Growth
+$86.4M
(+4.3%)
Cap. Flow
-$45.1M
Cap. Flow
% of AUM
-2.18%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
1
Closed
2
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$35M |
| 2 |
Johnson & Johnson
JNJ
|
+$9.85M |
| 3 |
UiPath
PATH
|
+$316K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 96.46% |
| 2 | Financials | 2.73% |
| 3 | Technology | 0% |
Similar funds
PB
BWLSA
SWM
AFA
CDWM
KLCMU
SWA
BFG
Robert Wood Johnson Foundation's Q2 2023 Portfolio in Review
As of Q2 2023, Robert Wood Johnson Foundation held 6 positions worth $2.07B, up 4.3% from $1.99B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Robert Wood Johnson Foundation's Q2 2023 filing shows 1 reduced and 2 closed positions. The largest sale was Royalty Pharma, an estimated $35M.
By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 96% a quarter earlier, followed by Financials and Technology.
- Robert Wood Johnson Foundation's biggest Q2 2023 reduction was Johnson & Johnson, cutting an estimated $9.85M.
- Robert Wood Johnson Foundation fully exited Royalty Pharma in Q2 2023, selling an estimated $35M.
- Robert Wood Johnson Foundation's ten largest holdings make up 100% of its $2.07B portfolio in Q2 2023.
- Robert Wood Johnson Foundation opened 0 new positions and closed 2 in Q2 2023.
- Robert Wood Johnson Foundation's portfolio value rose 4.3% quarter-over-quarter to $2.07B.
Based on Robert Wood Johnson Foundation's 13F filing for Q2 2023, filed 11 Aug 2023.